By Haley Mickey Scientists in Britain have discovered a protein which may be used as a target for a new tuberculosis vaccine. This discovery from Imperial College London could be a first step in the eradication of tuberculosis because though a TB vaccine currently exists — the Bacillus Calmette-Guerin, or BCG vaccine — it is […]
HIV protein unveils vaccine target
An international study headed by a UC Davis scientist describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet observed in nature. The finding could reveal new targets for vaccines to prevent HIV infection and AIDS. A paper describing the work was published […]
Inovio Pharmaceuticals Receives Grant for Multi-Vaccine DNA Delivery
Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development BLUE BELL, Pa., March 21, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a U.S. Department of […]
Vaccines on horizon for AIDS, Alzheimer's, herpes
By Linda A. Johnson MARIETTA, Pa. (AP) – Malaria. Tuberculosis. Alzheimer’s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler’s diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Many could be on the market in five years or less. Contrast that with five years ago, […]
Interview: Pfizer vaccine unit eyes adults, infectious disease
By Maureen Martino When Pfizer was searching for a major acquisition in 2009, it saw a lot it liked in Wyeth–including an established vaccine group that could jump-start its own efforts in that area. Pfizer had a nascent vaccine group was doing research but it didn’t have any products on the market. After the buy, the world’s […]
